Changes

Jump to: navigation, search
no edit summary
|}
===Regimen {{#subobject:0f2246|Variant=1}}===
{| class="wikitable" style="width: 5075%; text-align:center;" !style="width: 2533%"|Study!style="width: 2533%"|Years of enrollment!style="width: 33%"|[[Levels_of_Evidence#Evidence|Evidence]]
|-
|[https://wwwdoi.natureorg/10.com1038/sj.leu/journal/v16/n7/full/2402526a.html 2402526 Takeuchi et al. 2002 (JALSG-ALL93)]|1993-1997
|style="background-color:#91cf61"|Non-randomized
|-
===References===
# '''JALSG-ALL93:''' Takeuchi J, Kyo T, Naito K, Sao H, Takahashi M, Miyawaki S, Kuriyama K, Ohtake S, Yagasaki F, Murakami H, Asou N, Ino T, Okamoto T, Usui N, Nishimura M, Shinagawa K, Fukushima T, Taguchi H, Morii T, Mizuta S, Akiyama H, Nakamura Y, Ohshima T, Ohno R. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia. 2002 Jul;16(7):1259-66. [https://wwwdoi.natureorg/10.com1038/sj.leu/journal/v16/n7/full/2402526a.html 2402526 link to original article] [https://pubmed.ncbi.nlm.nih.gov/12094249 PubMed]
==Cytarabine, Daunorubicin, L-Asparaginase, Vincristine, Dexamethasone {{#subobject:5a7eda|Regimen=1}}==
LookupUsers, editors, emailconfirmed, Administrators
14,662
edits

Navigation menu